Recent Finacing
Recent Raise
NuCana is an Edinburgh-based clinical-stage biopharmaceutical company developing anti-cancer ProTide nucleoside analogues, advancing Acelarin for pancreatic, biliary, lung and ovarian cancers and progressing additional ProTide candidates into clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
